Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe (Primary) | PRIMARYEUR | Univ | 6,285 | 19,868,946 | -0.13% | -0.45% | 0.12% | 0.75% | 3.93% | 9.65% |
Healthcare | HEALTHCARE | Sector | 580 | 2,184,811 | -0.19% | 0.77% | 7.10% | -1.20% | -2.20% | -11.69% |
Biopharmaceuticals | BIOPHARMA | SubSec | 182 | 1,678,620 | -0.40% | 1.02% | 9.30% | -0.89% | -3.09% | -15.21% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 70 | 368,047 | -1.65% | -1.10% | 14.03% | -21.11% | -19.18% | -46.47% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 6 | 6,367 | 4.49% | 8.88% | 27.96% | 523.51% | 598.41% | 373.80% |
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 18 | 52,256 | -3.22% | -1.05% | 18.87% | 30.97% | 47.38% | 67.80% |
Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 6 | 1,455 | 0.67% | 1.29% | 15.89% | 18.03% | 44.19% | 34.94% |
Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 13 | 249,602 | -2.82% | -2.32% | 15.15% | -30.94% | -31.83% | -59.69% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 70 | 368,047 | -1.65% | -1.10% | 14.03% | -21.11% | -19.18% | -46.47% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 4 | 45,356 | 1.90% | 3.31% | 10.72% | 25.11% | 56.13% | 75.22% |
Respiratory System Biopharmaceuticals | RESPIRATORY | SubInd | 2 | 305 | 0.50% | 3.77% | 10.00% | 31.09% | 64.40% | 59.57% |
Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,285 | 19,868,946 | -0.20% | -0.06% | 1.05% | 0.00% | 4.22% | 10.91% |
Hematology Biopharmaceuticals | HEMATOLOGY | SubInd | 2 | 10,247 | 0.80% | -3.83% | 0.80% | -8.91% | -5.41% | -14.70% |
Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 5 | 1,394 | 0.96% | -5.03% | -0.83% | -9.83% | 0.19% | 23.83% |
Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 4 | 163 | 6.02% | 6.85% | -3.45% | 11.88% | 15.27% | 33.29% |
Urology Biopharmaceuticals | UROLOGY | SubInd | 5 | 342 | 0.49% | -3.07% | -4.53% | -6.75% | -6.75% | -6.75% |
Ophthalmology Biopharmaceuticals | OPHTHALMOLOGY | SubInd | 5 | 559 | 1.73% | -2.48% | -6.73% | -20.44% | -14.67% | -53.27% |
* Colors indicate performance relative to the benchmark.